Table 3.
Cases / N | 188 / 3,714 | p Value | 171 / 3,542 | p Value | 153 / 2,958 | p Value | |
---|---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | |||||
Age and Sex Adjusted | Age, Sex, and APOEε4 Adjusted | Multivariable Adjusteda | |||||
Alzheimer’s disease | Per SD | 1.06 (0.92–1.23) | .709 | 1.11 (0.96–1.29) | .153 | 1.10 (0.95–1.29) | .214 |
Q1 | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | ||||
Q2 | 0.49 (0.30–0.79) | .003 | 0.49 (0.29–0.83) | .008 | 0.44 (0.25–0.78) | .005 | |
Q3 | 0.73 (0.48–1.13) | .157 | 0.81 (0.52–1.27) | .350 | 0.91 (0.57–1.46) | .705 | |
Q4 | 0.71 (0.45–1.10) | .120 | 0.72 (0.45–1.15) | .163 | 0.74 (0.45–1.23) | .251 | |
Q5 | 0.90 (0.59–1.37) | .612 | 0.98 (0.63–1.52) | .930 | 0.93 (0.58–1.49) | .758 | |
Q1 vs. Q2–Q5 | 1.44 (1.04–2.00) | .029 | 1.35 (0.95–1.92) | .097 | 1.34 (0.92–1.95) | .129 |
Notes: APO = apolipoprotein; CI = confidence interval; HR = hazard ratio; Q = quartile.
aAdjusted for age, sex, high school degree, APOEε4 allele status, log plasma homocysteine, systolic blood pressure, diastolic blood pressure, antihypertensive medication, total cholesterol, current smoking, prevalent cardiovascular disease, diabetes, stroke, and atrial fibrillation.
p Values less than .05 are bolded to highlight statistical significance.